Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Newer valpromide analogues for treating epilepsy

July 14, 1997

Once-daily extended-release venlafaxine evaluated in depression

July 11, 1997

Pharmacokinetic, drug interaction and clinical results with ziprasidone

July 11, 1997

Phase II/III results for Seroquel

July 11, 1997

Natural products for hyperlipidemia

July 11, 1997

ETA receptor blockade for counteracting effects of angiotensin II

July 11, 1997

n-3 fatty acids for prevention of restenosis

July 11, 1997

Immunological effects of HMG-CoA reductase inhibitors in humans

July 11, 1997

Magnesium implicated in death from cardiovascular disease

July 11, 1997

Cardiovascular effects of psychotropic drugs

July 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...